Lin281632

CAS No. 108825-65-6

Lin281632( Lin28 1632 | Lin-28 1632 | Lin 28 163 )

Catalog No. M27896 CAS No. 108825-65-6

Lin281632 is an inhibitor of RNA binding protein Lin28 and bromodomain. Lin281632 promotes mESC differentiation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 80 Get Quote
10MG 140 Get Quote
25MG 295 Get Quote
50MG 507 Get Quote
100MG 714 Get Quote
500MG 1503 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Lin281632
  • Note
    Research use only, not for human use.
  • Brief Description
    Lin281632 is an inhibitor of RNA binding protein Lin28 and bromodomain. Lin281632 promotes mESC differentiation.
  • Description
    Lin281632 is an inhibitor of RNA binding protein Lin28 and bromodomain. Lin281632 promotes mESC differentiation.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Lin28 1632 | Lin-28 1632 | Lin 28 163
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    mannitol-1-phosphate dehydrogenase (M1PDH)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    108825-65-6
  • Formula Weight
    281.319
  • Molecular Formula
    C15H15N5O
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (177.74 mM)
  • SMILES
    CN(C(C)=O)c1cccc(c1)-c1ccc2nnc(C)n2n1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Allocco JJ, et al. Nitrophenide (Megasul) blocks Eimeria tenella development by inhibiting the mannitol cycle enzyme mannitol-1-phosphate dehydrogenase. J Parasitol. 2001 Dec;87(6):1441-8.
molnova catalog
related products
  • Scutebarbatine B

    Scutebarbatine B shows weak cytotoxicity with IC50 values ranging from 35.11 to 42.73 μM against K562 cell lines and HL60 cell lines.

  • DCZ0415

    DCZ0415 induces antimyeloma activity in vitro, in vivo and in primary cells of drug-resistant myeloma patients. DCZ0415 is a potent TRIP13 inhibitor that can impair the repair of non-homologous end junctions and inhibit NF-κB activity.DCZ0415 (10, 20 μM; 72 hours) showed a marked reduction in colony formation, indicating that it inhibited cell proliferation.

  • Caulilexin C

    Caulilexin C shows inhibitory activity on human Acyl CoA: cholesterol transferase I (hACATI) and on human Acyl CoA: cholesterol transferase 2 (hACAT2) at 100 mug/ml.